Essilorluxottica Acquires Retinai, Accelerating Transformative AI And Data-Powered Eye Health Solutions
EssilorLuxottica announces the acquisition of Ikerian AG, operating under the RetinAI brand, specializing in AI and data management in eyecare.
This move reinforces the Group’s med-tech journey, adding advanced software powered by machine learning and computer vision. These solutions streamline clinical, research and pharmaceutical workflows, and deliver actionable AI-driven insights that empower healthcare professionals and enhance patient care.
RetinAI develops advanced tools to collect, process and grade large-scale retinal images and biomarker datasets. RetinAI partners with pharmaceutical companies and research organizations that leverage proprietary real-world evidence to accelerate clinical studies and drug development.
Acquisition of RetinAI accelerates transformative AI and data-powered eye health solutions.
Author summary: EssilorLuxottica acquires RetinAI for AI-powered eye health solutions.